These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 2969764

  • 1. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF, Sanberg PR, Norman AB.
    Brain Res; 1988 May 31; 450(1-2):403-7. PubMed ID: 2969764
    [Abstract] [Full Text] [Related]

  • 2. Chronic treatment with MK-801 increases the quinolinic acid-induced loss of D-1 dopamine receptors in rat striatum.
    Norman AB, Ford LM, Kolmonpunporn M, Sanberg PR.
    Eur J Pharmacol; 1990 Feb 13; 176(3):363-6. PubMed ID: 2139415
    [Abstract] [Full Text] [Related]

  • 3. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
    Ossowska K, Karcz M, Wardas J, Wolfarth S.
    Eur J Pharmacol; 1990 Jul 03; 182(2):327-34. PubMed ID: 1975782
    [Abstract] [Full Text] [Related]

  • 4. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ, Albers LJ, Le H, Creese I.
    J Pharmacol Exp Ther; 1986 Sep 03; 238(3):846-54. PubMed ID: 3018223
    [Abstract] [Full Text] [Related]

  • 5. Lesions of the entopeduncular nucleus and the subthalamic nucleus reduce dopamine receptor antagonist-induced catalepsy in the rat.
    Zadow B, Schmidt WJ.
    Behav Brain Res; 1994 May 30; 62(1):71-9. PubMed ID: 7917035
    [Abstract] [Full Text] [Related]

  • 6. Differential loss of neurochemical markers following quinolinic acid-induced lesions of rat striatum.
    Norman AB, Ford LM, Sanberg PR.
    Exp Neurol; 1991 Oct 30; 114(1):132-5. PubMed ID: 1680744
    [Abstract] [Full Text] [Related]

  • 7. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
    Wardas J, Pietraszek M, Ossowska K, Wolfarth S.
    Pol J Pharmacol; 1995 Oct 30; 47(4):349-53. PubMed ID: 8616516
    [Abstract] [Full Text] [Related]

  • 8. Nicotine potentiation of haloperidol-induced catalepsy: striatal mechanisms.
    Sanberg PR, Emerich DF, el-Etri MM, Shipley MT, Zanol MD, Cahill DW, Norman AB.
    Pharmacol Biochem Behav; 1993 Oct 30; 46(2):303-7. PubMed ID: 8265684
    [Abstract] [Full Text] [Related]

  • 9. D-1 dopamine receptor changes after striatal quinolinic acid lesion.
    Barone P, Tucci I, Parashos SA, Chase TN.
    Eur J Pharmacol; 1987 Jun 12; 138(1):141-5. PubMed ID: 2957219
    [Abstract] [Full Text] [Related]

  • 10. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I, Kawano M, Kaneyuki H, Suetsugi M, Usami K, Hirano H, Mizuki Y, Yamada M.
    Pharmacol Biochem Behav; 1997 Sep 12; 58(1):103-8. PubMed ID: 9264077
    [Abstract] [Full Text] [Related]

  • 11. The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents.
    Gentzel RC, Toolan D, Roberts R, Koser AJ, Kandebo M, Hershey J, Renger JJ, Uslaner J, Smith SM.
    Neuropharmacology; 2015 Dec 12; 99():256-63. PubMed ID: 26044638
    [Abstract] [Full Text] [Related]

  • 12. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration.
    Ushijima I, Mizuki Y, Suetsugi M, Akimoto T, Yamada M.
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May 12; 22(4):709-21. PubMed ID: 9682282
    [Abstract] [Full Text] [Related]

  • 13. Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist.
    Meller E, Kuga S, Friedhoff AJ, Goldstein M.
    Life Sci; 1985 May 13; 36(19):1857-64. PubMed ID: 3157851
    [Abstract] [Full Text] [Related]

  • 14. Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors.
    Hess EJ, Norman AB, Creese I.
    J Neurosci; 1988 Jul 13; 8(7):2361-70. PubMed ID: 2907912
    [Abstract] [Full Text] [Related]

  • 15. In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390.
    Hjorth S, Carlsson A.
    J Neural Transm; 1988 Jul 13; 72(2):83-97. PubMed ID: 2968439
    [Abstract] [Full Text] [Related]

  • 16. One year treatment with haloperidol or clozapine fails to alter neostriatal D1- and D2-dopamine receptor sensitivity in the rat.
    Ashby CR, Hitzemann R, Rubinstein JE, Wang RY.
    Brain Res; 1989 Jul 24; 493(1):194-7. PubMed ID: 2570618
    [Abstract] [Full Text] [Related]

  • 17. Lateral hypothalamus-zona incerta region as an output station for the catalepsy induced by the blockade of striatal D1 and D2 dopamine receptors.
    Ossowska K, Wardas J, Golembiowska K, Wolfarth S.
    Brain Res; 1990 Jan 08; 506(2):311-5. PubMed ID: 2154287
    [Abstract] [Full Text] [Related]

  • 18. D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways [corrected].
    Ogren SO, Fuxe K.
    Neurosci Lett; 1988 Mar 10; 85(3):333-8. PubMed ID: 2966309
    [Abstract] [Full Text] [Related]

  • 19. Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density.
    Masuo Y, Montagne MN, Pélaprat D, Scherman D, Rostène W.
    Brain Res; 1990 Jun 18; 520(1-2):6-13. PubMed ID: 2169955
    [Abstract] [Full Text] [Related]

  • 20. Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats.
    Hauber W, Neuscheler P, Nagel J, Müller CE.
    Eur J Neurosci; 2001 Oct 18; 14(8):1287-93. PubMed ID: 11703457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.